The first large phase 3 trial of a candidate coronavirus vaccine in the U.S. began today (July 27). The biotech company Moderna is conducting the phase 3 trial, called COVE (Coronavirus Efficacy), in collaboration with the National Institute of […]
Click here to view original web page at Late-stage coronavirus vaccine trial starts today in the US
